Abstract
Aim
The aim of this study was to assess the prevalence of delirium in advanced cancer patients admitted to different palliative care services in Italy and possible related factors. The secondary outcome was to assess the changes of delirium after 1 week of palliative care.
Methods
A consecutive sample of patients was screened for delirium in period of 1 year in seven palliative care services. General data, including primary tumor, age, gender, concomitant disease, palliative prognostic score (PaP), and Karnofsky status, were collected. Possible causes or factors associated with delirium were looked for. The Edmonton Symptom Assessment Scale was used to assess physical and psychological symptoms and the Memorial Delirium Assessment Scale (MDAS) to assess the cognitive status of patients, at admission (T0) and 1 week after palliative care (T7).
Results
Of 848 patients screened, 263 patients were evaluated. Sixty-six patients had only the initial evaluation. The mean Karnofsky status was 34.1 (SD = 6.69); the mean PaP score at admission was 6.9 (SD = 3.97). The mean duration of palliative care assistance, equivalent to survival, was 38.4 days (SD = 48, range 2–220). The mean MDAS values at admission and after 1 week of palliative care were 6.9 (SD = 6.71) and 8.8 (SD = 8.26), respectively. One hundred ten patients (41.8%) and 167 patients (67.3%) had MDAS values ≥ 7 at admission and after 1 week of palliative care, respectively. Age, dehydration, cachexia, chemotherapy in the last three months, and intensity of drowsiness and dyspnea were independently associated with a MDAS > 7. A worsening of drowsiness, the use of opioids, and the use of corticosteroids were independently associated with changes of MDAS from T0 to T7.
Conclusion
Although the prevalence of delirium seems to be similar to that reported in other acute settings, delirium tended to worsen or poorly responded to a palliative care treatment. Some clinical factors were independently associated with delirium. This information is relevant for decision-making when delirium does not change despite a traditional intervention. Continuous assessment of delirium should be performed in these settings to detect deterioration of cognitive function. Further studies should elucidate whether an earlier approach to palliative care would decrease the prevalence of delirium at a late stage of disease.
References
Agar MR, Quinn SJ, Crawford GB, Ritchie CS, Phillips JL, Collier A, Currow DC (2016) Predictors of mortality for delirium in palliative care. J Palliat Med 19:1205–1209
de la Cruz M, Ransing V, Yennu S, Wu J, Liu D, Reddy A, Delgado-Guay M, Bruera E (2015) The frequency, characteristics, and outcomes among cancer patients with delirium admitted to an acute palliative care unit. Oncologist 20:1425–1431
de la Cruz M, Noguera A, San Miguel-Arregui MT, Williams J, Chisholm G, Bruera E (2015) Delirium, agitation, and symptom distress within the final seven days of life among cancer patients receiving hospice care. Palliat Support Care 13:211–216
Caraceni A, Nanni O, Maltoni M, Piva L, Indelli M, Arnoldi E, Monti M, Montanari L, Amadori D, De Conno F (2000) Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on palliative care. Cancer 89:1145–1149
de la Cruz M, Yennu S, Liu D, Wu J, Reddy A, Bruera E (2017) Increased symptom expression among patients with delirium admitted to an acute palliative care unit. J Palliat Med. https://doi.org/10.1089/jpm.2016.0315
Mercadante S, Fulfaro F, Casuccio A, Barresi L (1999) Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manag 18:347–352
Lawlor PG, Bush SH (2015) Delirium in patients with cancer: assessment, impact, mechanisms and management. Nat Rev Clin Oncol 12:77–92
Finucane AM, Lugton J, Kennedy C, Spiller JA (2016) The experiences of caregivers of patients with delirium, and their role in its management in palliative care settings: an integrative literature review. Psychooncology. https://doi.org/10.1002/pon.4140
Hey J, Hosker C, Ward J, Kite S, Speechley H (2015) Delirium in palliative care: detection, documentation and management in three settings. Palliat Support Care. 13:1541–1545
de la Cruz M, Fan J, Yennu S, Tanco K, Shin S, Wu J, Liu D, Bruera E (2015) The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Support Care Cancer 23:2427–2433
Porteous A, Dewhurst F, Gray WK, Coulter P, Karandikar U, Kiltie R, Lowery L, MacCormick F, Paxton A, Pickard J, Rowley G, Vidrine J, Walmsley R, Waterfield K, Weiand D, Grogan E (2016) Screening for delirium in specialist palliative care inpatient units: perceptions and outcomes. Int J Palliat Nurs 22:444–447
Hosie A, Lobb E, Agar M, Davidson PM, Phillips J (2014) Identifying the barriers and enablers to palliative care nurses’ recognition and assessment of delirium symptoms: a qualitative study. J Pain Symptom Manag 48:815–830
Detroyer E, Clement PM, Baeten N, Pennemans M, Decruyenaere M, Vandenberghe J, Menten J, Joosten E, Milisen K (2014) Detection of delirium in palliative care unit patients: a prospective descriptive study of the Delirium Observation Screening Scale administered by bedside nurses. Palliat Med 28:79–86
Shin SH, Hui D, Chisholm GB, Kwon JH, San-Miguel MT, Allo JA, Yennurajalingam S, Frisbee-Hume SE, Bruera E (2014) Characteristics and outcomes of patients admitted to the acute palliative care unit from the emergency center. J Pain Symptom Manag 47:1028–1034
Hui D, dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E (2015) Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: a prospective observational study. Palliat Med 29:826–833
Bush SH, Bruera E (2009) The assessment and management of delirium in cancer patients. Oncologist 14:1039–1049
Grassi L, Caraceni A, Beltrami E, Borreani C, Zamorani M, maltoni M, Monti M, Luzzani M, Mercadante S, De Conno F (2001) Assessing delirium in cancer patients. The Italian versions of the delirium rating scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manag 21:59–68
Mercadante S, Vitrano V (2010) Palliative care in Italy: problem areas emerging from the literature. Minerva Anestesiol 76:1060–1071
Maltoni M, Nanni O, Pirovano M et al (1999) Successful validation of the Palliative Prognostic Score in terminally ill cancer patients. Italian multicenter study group on palliative care. J Pain Symptom Manag 17:240–247
Maltoni M, Scarpi E, Pittureri C, Martini F, Montanari L, Amaducci E, Derni S, Fabbri L, Rosati M, Amadori D, Nanni O (2012) Prospective comparison of prognostic scores in palliative care cancer populations. Oncologist 17:446–454
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9
Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S (1997) The Memorial Delirium Assessment Scale. J Pain Symptom Manag 13:128–137
Grassi L, Caraceni A, Mitchell AJ, Nanni MG, Berardi MA, Caruso R, Riba M (2015) Management of delirium in palliative care: a review. Curr Psychiatry Rep 17:550
Mercadante S, Valle A, Sabba S, Orlando A, Guolo F, Gulmini L, Ori S, Bellingardo R, Casuccio A (2013) Pattern and characteristics of advanced cancer patients admitted to hospices in Italy. Support Care Cancer 21:935–939
Mercadante S, Adile C, Ferrera P, Cortegiani A, Casuccio A (2017) Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit. Curr Res Med Opin 33(7):1303–1308
Lawlor PG, Gagnon B, Mancini IL, Pereira J, Hanson J, Suarez-Almazor ME, Bruera E (2000) Occurrence, causes, and outcome of delirium in patients with advanced cancer. Arch Inter Med 160:786–794
Meier DE (2012) Pain as a cause of agitated delirium. Arch Intern Med 172:1130
Gagnon P, Allard P, Mâsse B, DeSerres M (2000) Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manag 19:412–426
Mercadante S, Casuccio A, Pumo S, Fulfaro F (2000) Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender. Support Care Cancer 8:123–130
Kloke M, Rapp M, Bosse B, Kloke O (2000) Toxicity and/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center. Support Care Cancer 8:479–486
Mercadante S, Porzio G, Valle A, Aielli F, Casuccio A (2014) Palliative sedation in patients with advanced cancer followed at home: a prospective study. J Pain Symptom Manag 47:860–866
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mercadante, S., Masedu, F., Balzani, I. et al. Prevalence of delirium in advanced cancer patients in home care and hospice and outcomes after 1 week of palliative care. Support Care Cancer 26, 913–919 (2018). https://doi.org/10.1007/s00520-017-3910-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3910-6